HK1093436A1 - Medicine for cancer therapy - Google Patents

Medicine for cancer therapy

Info

Publication number
HK1093436A1
HK1093436A1 HK07100198.3A HK07100198A HK1093436A1 HK 1093436 A1 HK1093436 A1 HK 1093436A1 HK 07100198 A HK07100198 A HK 07100198A HK 1093436 A1 HK1093436 A1 HK 1093436A1
Authority
HK
Hong Kong
Prior art keywords
medicine
lactoferrin
cancer therapy
drug
antibody
Prior art date
Application number
HK07100198.3A
Other languages
English (en)
Inventor
Kiyohiko Hatake
Yasuhito Terui
Yuji Mishima
Akio Yamada
Takuma Sakurai
Takehito Itoh
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Priority to HK09107583.9A priority Critical patent/HK1128113A1/xx
Publication of HK1093436A1 publication Critical patent/HK1093436A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK07100198.3A 2004-03-19 2007-01-05 Medicine for cancer therapy HK1093436A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK09107583.9A HK1128113A1 (en) 2004-03-19 2007-01-05 Drug for cancer therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004080454 2004-03-19
PCT/JP2005/004123 WO2005089788A1 (ja) 2004-03-19 2005-03-09 癌治療のための薬剤

Publications (1)

Publication Number Publication Date
HK1093436A1 true HK1093436A1 (en) 2007-03-02

Family

ID=34993444

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09107583.9A HK1128113A1 (en) 2004-03-19 2007-01-05 Drug for cancer therapy
HK07100198.3A HK1093436A1 (en) 2004-03-19 2007-01-05 Medicine for cancer therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09107583.9A HK1128113A1 (en) 2004-03-19 2007-01-05 Drug for cancer therapy

Country Status (14)

Country Link
US (1) US7419667B2 (xx)
EP (1) EP1726310B1 (xx)
JP (1) JP3998702B2 (xx)
KR (1) KR100773259B1 (xx)
CN (2) CN1838965B (xx)
AT (1) ATE541581T1 (xx)
AU (1) AU2005224209B2 (xx)
CA (1) CA2533753C (xx)
DK (1) DK1726310T3 (xx)
ES (1) ES2381189T3 (xx)
HK (2) HK1128113A1 (xx)
NZ (1) NZ544448A (xx)
PT (1) PT1726310E (xx)
WO (1) WO2005089788A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054908A1 (en) * 2004-11-19 2006-05-26 Fonterra Corporate Research And Development Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
US8455450B2 (en) * 2006-12-21 2013-06-04 Biokine Therapeutics Ltd. Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof
CA2699006A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
ES2462517T3 (es) 2009-06-14 2014-05-23 Biokine Therapeutics Ltd. Terapia con péptidos para aumentar los niveles de plaquetas
EP2841084B1 (en) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
KR101455306B1 (ko) * 2012-07-17 2014-10-27 엘에스엠 주식회사 세포 증식 촉진용 사람 락토페린의 펩신 가수분해물 및 이의 제조 방법
JPWO2016056665A1 (ja) * 2014-10-08 2017-08-10 学校法人慶應義塾 白血球の細胞外トラップ形成の阻害剤
AU2016291817A1 (en) 2015-07-16 2018-02-22 Biolinerx Ltd. Compositions and methods for treating cancer
IL258931B (en) 2015-10-06 2022-09-01 Univ Minnesota Medicinal compounds and methods
CA3014530A1 (en) 2016-02-23 2017-08-31 Biolinerx Ltd. Methods of treating acute myeloid leukemia
CN113354726B (zh) * 2021-06-11 2022-12-27 南方科技大学 乳铁蛋白活性肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351337A (ja) 1986-08-22 1988-03-04 Snow Brand Milk Prod Co Ltd 抗腫瘍剤
JPS63186260A (ja) 1987-01-28 1988-08-01 Minolta Camera Co Ltd 作像装置
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3110078B2 (ja) 1991-06-21 2000-11-20 森永乳業株式会社 高純度抗菌性ペプチドの大量製造法
EP0629347B1 (en) * 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
JP3207647B2 (ja) 1993-12-21 2001-09-10 森永乳業株式会社 ＩｇＧおよびＩｇＭクラスの抗体産生を促進する免疫賦活剤
JP3738042B2 (ja) 1994-05-17 2006-01-25 森永乳業株式会社 非経口用抗腫瘍剤
JP3506274B2 (ja) 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JP3693377B2 (ja) 1995-04-20 2005-09-07 森永乳業株式会社 生体内で感染防御作用を有するペプチド混合物と、このペプチド混合物を含有する組成物
JPH1059864A (ja) 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
JP2000229881A (ja) 1999-02-10 2000-08-22 Morinaga Milk Ind Co Ltd 癌疾患の予後改善剤

Also Published As

Publication number Publication date
CN101444624A (zh) 2009-06-03
JP3998702B2 (ja) 2007-10-31
AU2005224209A1 (en) 2005-09-29
JPWO2005089788A1 (ja) 2008-01-31
CN101444624B (zh) 2012-10-10
US20060204501A1 (en) 2006-09-14
KR20060095899A (ko) 2006-09-04
CN1838965B (zh) 2011-07-06
AU2005224209B2 (en) 2007-04-19
DK1726310T3 (da) 2012-05-07
ES2381189T3 (es) 2012-05-23
EP1726310B1 (en) 2012-01-18
KR100773259B1 (ko) 2007-11-05
PT1726310E (pt) 2012-04-27
CA2533753C (en) 2012-10-16
NZ544448A (en) 2009-10-30
EP1726310A4 (en) 2009-06-24
HK1128113A1 (en) 2009-10-16
CN1838965A (zh) 2006-09-27
WO2005089788A1 (ja) 2005-09-29
EP1726310A1 (en) 2006-11-29
ATE541581T1 (de) 2012-02-15
CA2533753A1 (en) 2005-09-29
US7419667B2 (en) 2008-09-02

Similar Documents

Publication Publication Date Title
HK1093436A1 (en) Medicine for cancer therapy
HK1109876A1 (en) Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
LUC00011I2 (xx)
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
NZ595313A (en) The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
NZ605871A (en) Treatment of sanfilippo syndrome type b
HUP0102489A2 (hu) Biokémiai anyagok alkalmazása emberi test szerveiben található simaizomsejtek összehúzódása okozta egészségi állapotok megelőzésére és kezelésére alkalmas készítményekben
ATE306290T1 (de) Tragbare vorrichtung zur verabreichung von medikamenten und dergleichen
WO2007087154A3 (en) Methods for enhancing therapeutic effects of a neurotoxin
MX2007005581A (es) Regimen de dosificacion mejorada de temozolomida para el tratamiento de cancer con base en el nivel de o6-metilguanidi-adn metiltransferasa del paciente.
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
WO2003063780A3 (en) Therapeutic composition for treatment of cancer by arginine depletion
WO2006134135A3 (en) Nutritional method for elderly people
HUP0103660A2 (hu) Mikróbaeredetű hialuronsavbontó enzimet tartalmazó gyógyászati készítmény
ATE453388T1 (de) Calciumtrifluoroacetat zur bereitung antiangiogenetischer arzneimittel
EP1374907A3 (en) Drug transport and delivery system
Borodin et al. Effect of the enteric sorbent noolit on the psychoemotional status in mice
RU2003110474A (ru) Способ лечения хронического тонзиллита
UA2701U (uk) Спосіб використання лікарських засобів та біологічно активних добавок без відома хворого
GEP20043317B (en) Ointment for Treatment of Purulent Diseases, Festering Wounds and Burns

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160309